基本信息
views: 278
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Professor San-Miguel has published extensively (over 900 original papers, H-Index: 148 and >100.000 citations) and has made seminal contributions to myeloma cell biology in areas such as immunophenotyping, risk of progression from monoclonal gammopathy of undetermined significance or smouldering MM into active MM, and minimal residual disease and therapeutics, including studies for new antimyeloma drugs at the preclinical and clinical levels (5 drugs/combinations approved by FDA/EMA under his leadership)
He has had a leading role in generating cooperative groups and networks (at both domestic and international level) (i.e. the Spanish myeloma group, the European myeloma network, the European network of minimal residual disease…). It should be highlighted the role of the Spanish Myeloma Group that include >80 hospitals and allows access to uniform treatments through innovative clinical trials to the Spanish myeloma patients..
His mentorship role includes >50 haematologists and >40 PhD students trained under his supervision, several of them are currently head of haematology departments at most prestigious Institutions in Spain and he has also promoted several new International leaders in the myeloma field.
Dr San Miguel´s reputation has been recognized by more than 30 Research Awards and Honors, such as: the Waldenstrom Award, the Kyle Life Achievement Award, the EHA-Carreras Award, the Thomas H. Ham-Wasserman Lecture Award, the Michaelli Award, the KNAW Bob Pinedo Award, Premio Fundación Lilly, Premio Rey Jaime I and the Spanish National Prize of Medicine.
He has had a leading role in generating cooperative groups and networks (at both domestic and international level) (i.e. the Spanish myeloma group, the European myeloma network, the European network of minimal residual disease…). It should be highlighted the role of the Spanish Myeloma Group that include >80 hospitals and allows access to uniform treatments through innovative clinical trials to the Spanish myeloma patients..
His mentorship role includes >50 haematologists and >40 PhD students trained under his supervision, several of them are currently head of haematology departments at most prestigious Institutions in Spain and he has also promoted several new International leaders in the myeloma field.
Dr San Miguel´s reputation has been recognized by more than 30 Research Awards and Honors, such as: the Waldenstrom Award, the Kyle Life Achievement Award, the EHA-Carreras Award, the Thomas H. Ham-Wasserman Lecture Award, the Michaelli Award, the KNAW Bob Pinedo Award, Premio Fundación Lilly, Premio Rey Jaime I and the Spanish National Prize of Medicine.
Research Interests
Papers共 1395 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Inés Sánchez-Moreno,Aritz Lasarte-Cia,Celia Martín-Otal,Noelia Casares,Flor Navarro,Marta Gorraiz,Patricia Sarrión,Sandra Hervas-Stubbs, Lorea Jordana,Juan Roberto Rodriguez-Madoz,Jesús San Miguel,Felipe Prosper,
crossref(2024)
biorxiv(2024)
Blood advancesno. 15 (2024): 3875-3879
A Medina-Herrera,I Vazquez,I Cuenca, J M Rosa-Rosa,B Ariceta, C Jimenez,M Fernandez-Mercado,M J Larrayoz,N C Gutierrez, M Fernandez-Guijarro,V Gonzalez-Calle,P Rodriguez-Otero,
Ignacio J. Cardona-Benavides,Irena Misiewicz-Krzeminska,Elizabeta A. Rojas,Cristina De Ramon,Antonio Sanz-Solas,Isabel Isidro,Dalia Quwaider, Aida M. Lopez-Guerrero, Myriam Cuadrado,Maria-Jose Calasanz,Laura Rosinol,Joaquin Martinez-Lopez,
HAEMATOLOGICAno. 3 (2024): 877-887
BLOODno. Supplement 1 (2023): 3433-3433
Load More
Author Statistics
#Papers: 1406
#Citation: 78260
H-Index: 124
G-Index: 248
Sociability: 9
Diversity: 3
Activity: 136
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn